CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan Merck KGaA - EUR - MRKd CFD

168.05
2.03%
0.60
Rendah: 164.6
Tinggi: 168.4
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.60
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.017913 %
Charges from borrowed part ($-0.72)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.017913%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.004309 %
Charges from borrowed part ($-0.17)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.004309%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang EUR
Margin 20%
Bursa efek Germany
Komisi perdagangan 0%

*Information provided by Capital.com

Merck KGaA ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

Key Stats
Prev. Close* 164.7
Open* 164.6
1-Year Change* -9.71%
Day's Range* 164.6 - 168.4
52 wk Range 153.10-202.80
Average Volume (10 days) 347.64K
Average Volume (3 months) 6.09M
Market Cap 21.80B
P/E Ratio 22.08
Shares Outstanding 434.78M
Revenue 22.23B
EPS 7.64
Dividend (Yield %) 1.30448
Beta 0.57
Next Earnings Date May 11, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 24, 2023 168.05 3.25 1.97% 164.80 168.80 164.35
Mar 23, 2023 164.70 -0.15 -0.09% 164.85 165.15 163.80
Mar 22, 2023 164.40 -2.35 -1.41% 166.75 167.05 164.40
Mar 21, 2023 166.90 2.50 1.52% 164.40 167.55 164.35
Mar 20, 2023 163.10 0.55 0.34% 162.55 164.75 162.10
Mar 17, 2023 163.80 -3.70 -2.21% 167.50 168.65 162.70
Mar 16, 2023 166.85 0.35 0.21% 166.50 167.35 164.70
Mar 15, 2023 165.20 -2.75 -1.64% 167.95 168.80 163.10
Mar 14, 2023 169.20 -1.30 -0.76% 170.50 171.10 166.75
Mar 13, 2023 169.65 -2.55 -1.48% 172.20 172.20 168.80
Mar 10, 2023 172.55 0.85 0.50% 171.70 173.65 171.50
Mar 9, 2023 173.75 -0.75 -0.43% 174.50 175.00 173.50
Mar 8, 2023 175.15 -1.25 -0.71% 176.40 177.10 174.30
Mar 7, 2023 177.25 -2.40 -1.34% 179.65 181.25 177.25
Mar 6, 2023 177.80 -1.55 -0.86% 179.35 179.35 177.60
Mar 3, 2023 178.85 -0.80 -0.45% 179.65 180.00 177.60
Mar 2, 2023 178.75 5.35 3.09% 173.40 180.10 173.20
Mar 1, 2023 176.40 -2.15 -1.20% 178.55 179.80 175.85
Feb 28, 2023 178.90 -2.35 -1.30% 181.25 181.70 178.65
Feb 27, 2023 182.60 -0.35 -0.19% 182.95 184.60 181.65

Merck KGaA - EUR Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 19687 17534 16152 14836 14517
Revenue 19687 17534 16152 14836 14517
Cost of Revenue, Total 7325 6782 5951 5342 5071
Gross Profit 12362 10752 10201 9494 9446
Total Operating Expense 15508 14549 14032 13109 12094
Selling/General/Admin. Expenses, Total 4855 4600 4686 4256 4234
Research & Development 2400 2262 2239 2220 2102
Depreciation / Amortization 589 636 923 979 1020
Interest Expense (Income) - Net Operating 1 62 3
Unusual Expense (Income) 184 85 389 339 -26
Other Operating Expenses, Total 154 184 -156 -89 -310
Operating Income 4179 2985 2120 1727 2423
Interest Income (Expense), Net Non-Operating -255 -350 -338 -209 -243
Other, Net 0 -5 -47 -57 -51
Net Income Before Taxes 3924 2630 1735 1461 2129
Net Income After Taxes 3065 1993 1295 1093 2557
Minority Interest -10 -7 -3 -22 -10
Net Income Before Extra. Items 3055 1986 1292 1071 2547
Total Extraordinary Items 0 28 2303 57
Net Income 3055 1986 1320 3374 2604
Income Available to Common Excl. Extra. Items 3055 1987 1292 1071 2548
Income Available to Common Incl. Extra. Items 3055 1987 1320 3374 2605
Diluted Net Income 3055 1987 1320 3374 2605
Diluted Weighted Average Shares 434.566 434.792 434.211 434.794 434.778
Diluted EPS Excluding Extraordinary Items 7.03 4.57 2.97552 2.46324 5.86046
Dividends per Share - Common Stock Primary Issue 1.85 1.4 1.3 1.25 1.25
Diluted Normalized EPS 7.36072 4.71815 3.6442 3.04653 5.91727
Total Adjustments to Net Income 1 0 1
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 5198 5213 4973 4870 4631
Revenue 5198 5213 4973 4870 4631
Cost of Revenue, Total 1987 1959 1859 1813 1721
Gross Profit 3211 3254 3114 3057 2910
Total Operating Expense 4025 4174 3926 3821 3588
Selling/General/Admin. Expenses, Total 1374 1546 1376 1342 1280
Research & Development 586 590 660 585 574
Unusual Expense (Income) 5 -6 -1 0 6
Other Operating Expenses, Total 73 85 32 81 7
Operating Income 1173 1039 1047 1049 1043
Interest Income (Expense), Net Non-Operating -34 -47 -54 -95 -60
Other, Net 1 1
Net Income Before Taxes 1139 992 993 955 984
Net Income After Taxes 884 806 764 747 748
Minority Interest -3 -4 -3 -2 -1
Net Income Before Extra. Items 881 802 761 745 747
Net Income 881 802 761 745 747
Income Available to Common Excl. Extra. Items 880 802 761 745 747
Income Available to Common Incl. Extra. Items 880 802 761 745 747
Diluted Net Income 880 802 761 745 747
Diluted Weighted Average Shares 435.644 433.438 434.857 434.778 434.302
Diluted EPS Excluding Extraordinary Items 2.02 1.85032 1.75 1.71352 1.72
Dividends per Share - Common Stock Primary Issue 0 1.85 0 0 0
Diluted Normalized EPS 2.07345 1.80908 1.8827 1.90422 1.80927
Total Adjustments to Net Income -1 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 10982 9280 9003 9236 7455
Cash and Short Term Investments 1685 1234 598 2199 623
Cash & Equivalents 1511 1109 541 779 481
Short Term Investments 174 125 57 1420 142
Total Receivables, Net 4345 3910 4233 3738 3707
Accounts Receivable - Trade, Net 3853 3390 3644 3278 2923
Total Inventory 3900 3294 3342 2764 2632
Prepaid Expenses 570 519 493 435 338
Other Current Assets, Total 482 323 337 100 155
Total Assets 45362 41796 43811 36888 35621
Property/Plant/Equipment, Total - Net 7217 6421 6213 4811 4512
Property/Plant/Equipment, Total - Gross 14810 13228 12561 10551 9853
Accumulated Depreciation, Total -7593 -6808 -6348 -5740 -5340
Goodwill, Net 17004 15959 17141 13764 13582
Intangibles, Net 7612 7653 9175 7237 8317
Long Term Investments 3 1 419
Note Receivable - Long Term 922 830 746 614 41
Other Long Term Assets, Total 1622 1652 1533 1226 1295
Total Current Liabilities 10432 9231 11842 8517 8635
Accounts Payable 2380 1768 2054 1766 2195
Accrued Expenses 1204 975 791 799 778
Notes Payable/Short Term Debt 1434 515 2224 982 1173
Current Port. of LT Debt/Capital Leases 1062 1780 2307 1217 1590
Other Current Liabilities, Total 4352 4193 4466 3753 2899
Total Liabilities 24024 24850 25945 19688 21618
Total Long Term Debt 8270 9745 8588 6608 7947
Long Term Debt 7928 9418 8130 6608 7947
Deferred Income Tax 1411 1441 1828 1288 1489
Minority Interest 78 71 48 33 63
Other Liabilities, Total 3833 4362 3639 3242 3484
Total Equity 21338 16946 17866 17200 14003
Preferred Stock - Non Redeemable, Net 397 397 397 397 397
Common Stock 168 168 168 168 168
Additional Paid-In Capital 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 16673 14556 13236 12532 9902
Other Equity, Total 286 -1989 251 289 -278
Total Liabilities & Shareholders’ Equity 45362 41796 43811 36888 35621
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778
Capital Lease Obligations 342 327 458
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 11085 10982 10315 10182 10617
Cash and Short Term Investments 1445 2073 1665 1870 2298
Cash & Equivalents 1339 1899 1523 1825 2238
Short Term Investments 106 174 142 45 60
Total Receivables, Net 4705 4345 4207 4124 4226
Accounts Receivable - Trade, Net 4345 3853 3930 3771 3816
Total Inventory 4143 3900 3760 3564 3462
Other Current Assets, Total 792 664 683 624 631
Total Assets 46235 45362 43836 43145 43891
Property/Plant/Equipment, Total - Net 7303 7217 6761 6601 6552
Goodwill, Net 17761 17004 16670 16347 16541
Intangibles, Net 7549 7612 7628 7613 7765
Long Term Investments 905 914 794 744 770
Note Receivable - Long Term 35 35 39 39 38
Other Long Term Assets, Total 1597 1598 1629 1619 1608
Total Current Liabilities 10207 10432 9793 9820 10652
Accounts Payable 2356 2380 2132 2107 1937
Accrued Expenses 174 224 191 144 118
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 2345 2531 2770 3278 3347
Other Current Liabilities, Total 5332 5297 4700 4291 5250
Total Liabilities 23316 24024 23229 23852 24975
Total Long Term Debt 8286 8270 8195 8721 9001
Long Term Debt 8286 8270 8195 8721 9001
Deferred Income Tax 1389 1411 1374 1401 1440
Minority Interest 71 78 72 68 67
Other Liabilities, Total 3363 3833 3795 3842 3815
Total Equity 22919 21338 20607 19293 18916
Preferred Stock - Non Redeemable, Net 397 397 397 397
Common Stock 565 168 168 168 168
Additional Paid-In Capital 3814 3814 3814 3814 3814
Retained Earnings (Accumulated Deficit) 18540 16673 16556 15799 15240
Other Equity, Total 286 -328 -885 -703
Total Liabilities & Shareholders’ Equity 46235 45362 43836 43145 43891
Total Common Shares Outstanding 434.778 434.778 434.778 434.778 434.778
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line 3065 1994 1324 3396 2615
Cash From Operating Activities 4616 3477 2856 2219 2696
Cash From Operating Activities 1762 1938 1944 1812 1758
Non-Cash Items 62 -59 149 -2523 -250
Changes in Working Capital -273 -396 -561 -466 -1427
Cash From Investing Activities -1578 -1340 -6153 2191 -1147
Capital Expenditures -1421 -1563 -1021 -1016 -1311
Other Investing Cash Flow Items, Total -157 223 -5132 3207 164
Cash From Financing Activities -2504 -1522 1902 -2825 -1870
Financing Cash Flow Items -576 -519 -527 -607 -469
Total Cash Dividends Paid -181 -168 -162 -162 -155
Issuance (Retirement) of Debt, Net -1747 -835 2591 -2056 -1246
Foreign Exchange Effects 9 -40 5 -5 -30
Net Change in Cash 543 575 -1390 1580 -351
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line 884 3065 2258 1495 748
Cash From Operating Activities 840 4616 3571 2104 1216
Cash From Operating Activities 430 1762 1287 843 424
Non-Cash Items -24 62 46 25 6
Changes in Working Capital -450 -273 -20 -259 38
Cash From Investing Activities -1089 -1578 -1226 -587 -346
Capital Expenditures -498 -1421 -1155 -638 -362
Other Investing Cash Flow Items, Total -591 -157 -71 51 16
Cash From Financing Activities -315 -2504 -2184 -1054 6
Financing Cash Flow Items -100 -576 -575 -575 -55
Total Cash Dividends Paid 0 -181 -181 -181 0
Issuance (Retirement) of Debt, Net -215 -1747 -1428 -298 61
Foreign Exchange Effects 4 9 7 6 7
Net Change in Cash -560 543 168 469 883
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.8422 8842949 0 2022-09-27 LOW
MFS Investment Management Investment Advisor/Hedge Fund 4.9546 6403473 -182454 2023-03-14 LOW
Amundi Asset Management, SAS Investment Advisor/Hedge Fund 3.2526 4203687 497340 2023-03-17 HIGH
Fidelity Management & Research Company LLC Investment Advisor 3.0193 3902150 119050 2022-09-19 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.808 3629137 4766 2023-02-28 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3464 3032598 488031 2022-12-31 LOW
DWS Investment GmbH Investment Advisor/Hedge Fund 1.9688 2544582 60587 2023-02-28 LOW
FMR Investment Management (U.K.) Limited Investment Advisor 1.2736 1646059 -34717 2023-01-31 LOW
Deka Investment GmbH Investment Advisor/Hedge Fund 1.1402 1473631 79182 2023-02-28 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.0699 1382787 75497 2023-02-28 LOW
Fidelity International Investment Advisor 1.0391 1342977 1965 2023-01-31 LOW
Allianz Global Investors GmbH Investment Advisor 1.0097 1304906 1323 2023-01-31 LOW
Union Investment Privatfonds GmbH Investment Advisor 0.9614 1242564 0 2022-12-31 LOW
Eleva Capital SAS Investment Advisor 0.8919 1152665 25800 2022-10-31 MED
BNP Paribas Asset Management France SAS Investment Advisor/Hedge Fund 0.7859 1015743 3480 2023-02-28 LOW
California Public Employees' Retirement System Pension Fund 0.7543 974843 -146711 2021-06-30 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 0.7494 968528 -38810 2023-02-28 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.7336 948118 355 2023-02-28 LOW
Nuveen LLC Pension Fund 0.7261 938364 -1239 2023-02-28 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.665 859431 774 2023-01-31 LOW

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Proprietary & Advanced Pharmaceuticals

Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,798.80 Price
+0.420% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 3.0

Gold

1,978.85 Price
-0.760% 1D Chg, %
Biaya inap posisi Long -0.0179%
Biaya inap posisi short 0.0097%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

BTC/USD

27,836.80 Price
+1.530% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
Biaya inap posisi Long -0.0194%
Biaya inap posisi short -0.0025%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda